BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

251 related articles for article (PubMed ID: 7455231)

  • 1. [Cervical myelography with water-soluble nonionic contrast media (metrizamide and iopamidol) (author's transl)].
    Nuzzo G; Malaguti C; Mavilla L; Fagioli L; Trevisan C
    Radiol Med; 1980 Apr; 66(4):211-4. PubMed ID: 7455231
    [No Abstract]   [Full Text] [Related]  

  • 2. [1st trials of a new contrast medium, iopamidol, in the study of the spinal canal].
    Bories J; Chiras J; Drouineau J
    Ann Radiol (Paris); 1983 Dec; 26(8 Pt 2):789-92. PubMed ID: 6670841
    [No Abstract]   [Full Text] [Related]  

  • 3. [Myelography with B 15000, a new nonionic water-soluble contrast medium. Technical aspects and preliminary clinical experiences (author's transl)].
    Smaltino F; Ciccarelli R; Cirillo S; D'Auria T; Gambardella A; La Tessa G; Meoli S; Rotondo A; Santoro S
    Radiol Med; 1980 Apr; 66(4):203-10. PubMed ID: 7005985
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Clinical experience with iopamidol for myelography.
    Bockenheimer SA; Hillesheimer W
    AJNR Am J Neuroradiol; 1983; 4(3):314-6. PubMed ID: 6410731
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Iopamidol and metrizamide in cervical myelography: side effects, EEG, and CSF changes.
    Moschini L; Manara O; Bonaldi G; Cassinari V; Quilici N; Belloni G
    AJNR Am J Neuroradiol; 1983; 4(3):848-50. PubMed ID: 6410870
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Comparison of radiographic quality and adverse reactions in myelography with iopamidol and metrizamide.
    Bannon KR; Braun IF; Pinto RS; Manuell M; Sudilovsky A; Kricheff II
    AJNR Am J Neuroradiol; 1983; 4(3):312-3. PubMed ID: 6410730
    [TBL] [Abstract][Full Text] [Related]  

  • 7. [Cervical myelography with iopamidol].
    Bonafé A; Prère J; Bonaldi G; Marcovich Y; Lebec G; Manelfe C
    Ann Radiol (Paris); 1983 Dec; 26(8 Pt 2):783-8. PubMed ID: 6670840
    [No Abstract]   [Full Text] [Related]  

  • 8. [Side effects of 2 water-soluble contrast media used in myelography].
    Caillé JM
    Ann Radiol (Paris); 1983 Dec; 26(8 Pt 2):779-82. PubMed ID: 6689467
    [No Abstract]   [Full Text] [Related]  

  • 9. [Iopamidol: a complementary study in 42 patients with pathology indicating the need for myeloradiculography].
    Fredy D
    Ann Radiol (Paris); 1983 Dec; 26(8 Pt 2):793-6. PubMed ID: 6670842
    [No Abstract]   [Full Text] [Related]  

  • 10. Iopamidol vs. metrizamide myelography: clinical comparison of side effects.
    Trevisan C; Malaguti C; Manfredini M; Tampieri D
    AJNR Am J Neuroradiol; 1983; 4(3):306-8. PubMed ID: 6410728
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Clinical comparison of metrizamide and iopamidol for myelography.
    Turski PA; Sackett JF; Gentry LR; Strother CM; Matozzi F
    AJNR Am J Neuroradiol; 1983; 4(3):309-11. PubMed ID: 6410729
    [TBL] [Abstract][Full Text] [Related]  

  • 12. [Cervical myelography with water-soluble contrast medium (Metrizamide). Technique and preliminary results (author's transl)].
    Vogelsang H; Busse O; Schmidt R
    Rofo; 1976 Sep; 125(3):225-8. PubMed ID: 134947
    [TBL] [Abstract][Full Text] [Related]  

  • 13. A double-blind clinical trial of iopamidol versus metrizamide for lumbosacral myelography.
    Drayer BP; Vassallo C; Sudilovsky A; Luther JS; Wilkins RH; Allen S; Bates M
    J Neurosurg; 1983 Apr; 58(4):531-7. PubMed ID: 6338167
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Iopamidol in lumbar myelography.
    Kleefield J; Chirico-Post J; Levine HL; Srinivasan MK; Harris JM; Rommel AJ; Robbins AH
    Surg Neurol; 1983 Aug; 20(2):165-70. PubMed ID: 6224304
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Double blind study of the toxicity of intrathecal iopamidol and metrizamide in lumbar myelography.
    Vézina JL; Fox AJ
    J Can Assoc Radiol; 1984 Sep; 35(3):257-8. PubMed ID: 6501380
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Iopamidol vs metrizamide: a double blind study for cervical myelography.
    Drayer BP; Warner MA; Sudilovsky A; Luther J; Wilkins R; Allen S; Bates M
    Neuroradiology; 1982; 24(2):77-84. PubMed ID: 7177374
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Iopamidol for myelography. A clinical trial with a new non-ionic contrast medium.
    Peeters F; van Dongen K; Hekster R; Hoogland P; Thijssen H; Tjian T; Wilmink J; Althuisius H
    Diagn Imaging; 1983; 52(6):313-5. PubMed ID: 6357678
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Myelography with lopamidol.
    Lamb JT; Holland IM
    AJNR Am J Neuroradiol; 1983; 4(3):851-3. PubMed ID: 6410871
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Psychopathometric demonstration and quantification of mental disturbances following myelography with metrizamide and iopamidol.
    Galle G; Huk W; Arnold K
    Neuroradiology; 1984; 26(3):229-33. PubMed ID: 6738855
    [TBL] [Abstract][Full Text] [Related]  

  • 20. [Myeloradiculography with iopamidol and metrizamide. Comparative study].
    Bohutová J; Kolár J; Lerlová L
    Cesk Radiol; 1984 Feb; 38(1):23-7. PubMed ID: 6713587
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 13.